1,211 results on '"Halimi S"'
Search Results
102. Réflexions pour de nouvelles recommandations de traitement médicamenteux du diabète de type 2 après post-UKPDS, ACCORD, VADT, ADVANCE: Thoughts on new recommendations for the treatment of type 2 diabetes after the recent studies: UKPDS post-trial, ACCORD, VADT, ADVANCE
103. How do patients with type 2 diabetes perceive their disease? Insights from the French DIABASIS survey
104. Le contrôle glycémique en réanimation : spécificités chez les patients diabétiques
105. Capítulo 29 - Fichas clínicas
106. Chapitre 104 - Résultats de la chirurgie bariatrique sur le diabète
107. L’autosurveillance glycémique au cours du diabète de type 2 non insulinotraité : le contre !
108. Évaluation de la qualité de vie en éducation thérapeutique du patient diabétique : intérêts et limites des échelles de mesure standardisées
109. Gastroparésie chez le diabétique : comment poser le diagnostic et comment la traiter ?
110. DPP-4 inhibitors and GLP-1 analogues: for whom? Which place for incretins in the management of type 2 diabetic patients?
111. A prospective study of quality of life in 77 type 1 diabetic patients 12 months after a hospital therapeutic educational programme
112. Methodological aspects of crossover and maximum fat-oxidation rate point determination
113. Plasma 15-F 2t isoprostane concentrations are increased during acute fructose loading in type 2 diabetes
114. La vérité sur vos médicaments : 32 spécialistes répondent à toutes vos questions
115. Maladie de Forestier
116. Perspectives pour améliorer la prise en charge des patients diabétiques de type 2 sous insuline
117. Vitiligo : marqueur de co-morbidités auto-immunes
118. Liste des collaborateurs
119. Effects of a myocardial ischaemia-guided therapeutic program on survival and incidence of coronary events in asymptomatic patients with diabetes: the ARCADIA study
120. Type 2 diabetes mellitus: epidemiology, pathophysiology, unmet needs and therapeutical perspectives
121. One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study
122. Comparison of dinner with bedtime administration of insulin glargine in type 1 diabetic patients treated with basal-bolus regimen
123. Cortico-responsive encephalopathy associated with autoimmune thyroiditis (SREAT): about two case reports characterized by a gap between the diagnosis of autoimmune thyroiditis and neurological disorders
124. Zinc Modulates the Glucose Induced Rat Aortic Smooth Cell Proliferation
125. Zinc Protects Hela Cells Against the Glucose Induced Cytotoxic Effect
126. Liste des collaborateurs
127. Regulation of oxidative stress and inflammation by glycaemic control: evidence for reversible activation of the 5-lipoxygenase pathway in type 1, but not in type 2 diabetes
128. Evaluation of road traffic impact on the aquifers of the crossed areas. Application to Annaba plain crossed by (NR21, NR16 and NR44). Northeastern Algeria
129. Assessment of handicap in chronic dialysis diabetic patients (Uremidiab section study)
130. High prevalence of obstructive sleep apnoea syndrome in a Type 1 diabetic adult population: a pilot study
131. Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report
132. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control
133. Adenovirus-mediated catalase gene transfer reduces oxidant stress in human, porcine and rat pancreatic islets
134. Earlier triple therapy with pioglitazone in patients with type 2 diabetes
135. Albumin antioxidant capacity is modified by methylglyoxal
136. Prévention primaire cardio-rénale chez le diabétique de type 2: Étude Roadmap
137. Nouvelles stratégies thérapeutiques dans le diabète de type 2?
138. Les glitazones
139. Place des glitazones dans de futures recommandations cliniques
140. Matrix metalloproteinases and diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is a predictor of wound healing
141. Chapitre 29 - Fiches cliniques
142. Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans
143. Zinc Protects Human Endothelial Vascular Cells Against the Glucose Induced Cytotoxicity
144. Zinc 100 ppm Does not Improve Insulin Sensitivity of High Fructose Fed Rats Leading to Insulin Resistance
145. The Use of Stable Isotope Tracers to Explorate Zinc and Selenium Metabolism in Insulin Dependant Patients
146. Antioxidant Micronutriments Insulin-Sensitivity
147. Effects of ritanserin, a novel serotonin-s2 receptor antagonist, on the secretion of pituitary hormones in normal humans
148. Epidemiology, development and treatment of end-stage renal failure in Type 2 (non-insulin-dependent) diabetes mellitus: The case of mainland France and of overseas French territories
149. Initiating oral glucose-lowering therapy with metformin in tyape 2 diabetic patients: an evidence-based strategy to reduce the burden of late-developing diabetes complications
150. Cas clinique : Croyances, Ramadan et Diabète
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.